Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

First launch for inhaled smoking cessation product

Sep. 13, 1996

Known antipsychotic claimed for drug dependence

Sep. 13, 1996

Nicotine nasal spray codevelopment agreement

Aug. 23, 1996

ImmuLogic receives SBIR grant for cocaine vaccine research

Aug. 16, 1996

Nicoderm CQ approved for OTC use

Aug. 16, 1996

Sanwa Kagaku reveals selectin inhibitors

Aug. 9, 1996

Nicotrol launched on U.S. market as OTC

July 26, 1996

Data on withdrawal from benzodiazepine treatment

July 19, 1996

FDA approves Nicotrol for OTC marketing

July 12, 1996

Alza/HMR and Ciba-Geigy resolve nicotine patch patent disputes

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.